SYNER-G BIOPHARMA GROUP Trademark

Trademark Overview


On Thursday, September 16, 2021, a trademark application was filed for SYNER-G BIOPHARMA GROUP with the United States Patent and Trademark Office. The USPTO has given the SYNER-G BIOPHARMA GROUP trademark a serial number of 97030469. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by Syner-G Pharma Consulting, LLC. The SYNER-G BIOPHARMA GROUP trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies

Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences

Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others...
syner-g biopharma group

General Information


Serial Number97030469
Word MarkSYNER-G BIOPHARMA GROUP
Filing DateThursday, September 16, 2021
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7402522
Registration DateTuesday, May 28, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements


Description of MarkThe mark consists of a stylized pyramid with one side consisting of a solid triangle and the other side consisting of lines forming a triangle appearing to the left of the stylized word "SYNER-G" above the stylized words "BioPharma Group" with the words separated by a horizontal line.
Pseudo MarkSYNERGY BIOPHARMACEUTICAL GROUP
Goods and ServicesProviding business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies
Goods and ServicesRegulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences
NOT AVAILABLE"BIOPHARMA GROUP"
Goods and ServicesConsulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others in the field of design, planning, and implementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, October 21, 2021
Primary Code035
First Use Anywhere DateWednesday, October 20, 2021
First Use In Commerce DateWednesday, October 20, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 21, 2021
Primary Code042
First Use Anywhere DateWednesday, October 20, 2021
First Use In Commerce DateWednesday, October 20, 2021

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 21, 2021
Primary Code045
First Use Anywhere DateWednesday, October 20, 2021
First Use In Commerce DateWednesday, October 20, 2021

Trademark Owner History


Party NameSYNER-G BIOPHARMA GROUP LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFramingham, MA 01701

Party NameSYNER-G BIOPHARMA GROUP LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFramingham, MA 01701

Party NameSYNER-G BIOPHARMA GROUP LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressSOUTHBOROUGH, MA 01772

Party NameSyner-G Pharma Consulting, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouthborough, MA 01772

Trademark Events


Event DateEvent Description
Monday, September 20, 2021NEW APPLICATION ENTERED
Thursday, October 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 22, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 8, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 21, 2022ASSIGNED TO EXAMINER
Tuesday, June 21, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 21, 2022NON-FINAL ACTION E-MAILED
Tuesday, June 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 3, 2023SUSPENSION LETTER WRITTEN
Tuesday, January 3, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, January 3, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, April 2, 2024USE AMENDMENT FILED
Saturday, April 20, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, April 20, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 24, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, April 24, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED